MaltSci 麦伴科研

Appearance

Popular Reports / Immunology

This report is written by MaltSci based on the latest literature and research findings

What is the role of T cells in immune response? ​

Abstract ​

The immune system is a highly coordinated network that protects the host from pathogens while maintaining tolerance to self-antigens, with T cells playing a pivotal role in mediating adaptive immune responses. T cells originate from hematopoietic stem cells and mature in the thymus, undergoing critical selection processes to ensure functionality and self-tolerance. This review provides a comprehensive overview of T cell biology, focusing on their development, activation mechanisms, and functional roles in immune responses against infections and tumors. T cells can be classified into CD4+ T helper cells, which activate other immune cells, and CD8+ cytotoxic T cells, responsible for directly eliminating infected or malignant cells. Regulatory T cells maintain immune homeostasis, while memory T cells provide long-lasting immunity. The review discusses the activation of T cells through antigen presentation and co-stimulatory signals, highlighting the complexity of their interactions within the immune environment. Furthermore, the roles of T cells in cancer immunity and autoimmunity are explored, revealing the challenges and opportunities for therapeutic interventions. By synthesizing current knowledge on T cell functions, this review aims to inform the development of novel immunotherapies and vaccines, addressing health challenges related to infectious diseases, cancer, and autoimmune disorders.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 T Cell Development and Differentiation
    • 2.1 Origin and Maturation of T Cells
    • 2.2 Selection Processes in the Thymus
  • 3 Mechanisms of T Cell Activation
    • 3.1 Antigen Presentation and Recognition
    • 3.2 Co-stimulatory Signals and Cytokine Environment
  • 4 Types of T Cells and Their Functions
    • 4.1 CD4+ T Helper Cells
    • 4.2 CD8+ Cytotoxic T Cells
    • 4.3 Regulatory T Cells
    • 4.4 Memory T Cells
  • 5 T Cells in Immune Responses
    • 5.1 Role in Viral Infections
    • 5.2 Role in Bacterial Infections
    • 5.3 T Cells in Cancer Immunity
  • 6 T Cells and Autoimmunity
    • 6.1 Mechanisms of Autoimmune Responses
    • 6.2 Therapeutic Approaches Targeting T Cells
  • 7 Summary

1 Introduction ​

The immune system serves as a complex and highly coordinated network that protects the host from a wide array of pathogens while maintaining tolerance to self-antigens. Among the key players in this intricate system are T cells, a specialized subset of lymphocytes that are pivotal in mediating adaptive immune responses. T cells originate from hematopoietic stem cells in the bone marrow and undergo maturation and selection in the thymus, a process critical for ensuring both functionality and self-tolerance [1]. This selection process is essential, as it prevents the emergence of autoreactive T cells that could lead to autoimmune diseases [2]. The two primary types of T cells, CD4+ T helper cells and CD8+ cytotoxic T cells, orchestrate and execute immune responses, respectively. CD4+ T cells facilitate the activation of other immune cells, including B cells and macrophages, while CD8+ T cells are primarily responsible for directly eliminating infected or malignant cells [3].

The significance of T cells in immune responses cannot be overstated. They not only contribute to the clearance of pathogens but also play a crucial role in shaping the overall immune landscape, influencing both the magnitude and duration of the immune response [4]. Recent advances in immunology have expanded our understanding of T cell biology, revealing a diverse array of T cell subsets with distinct functions, including regulatory T cells (Tregs) and memory T cells. Tregs are essential for maintaining immune homeostasis and preventing excessive immune responses that can lead to tissue damage or autoimmunity [5]. Memory T cells, on the other hand, provide long-lasting immunity by rapidly responding to previously encountered antigens, a feature that is crucial for effective vaccination strategies [6].

Despite the critical roles T cells play in both protective immunity and the pathogenesis of various diseases, including cancer and autoimmune disorders, our understanding of their mechanisms of action remains incomplete. The activation of T cells involves a complex interplay of signals, including antigen presentation via Major Histocompatibility Complex (MHC) molecules, co-stimulatory signals, and cytokine signaling [7]. This review aims to provide a comprehensive overview of T cell biology, exploring their development, activation mechanisms, and functional roles in immune responses against viral and bacterial infections, as well as their involvement in cancer immunity and autoimmunity.

The organization of this review is structured as follows: Section 2 will discuss T cell development and differentiation, highlighting their origin, maturation, and the selection processes that occur in the thymus. Section 3 will delve into the mechanisms of T cell activation, detailing the roles of antigen presentation and the cytokine environment. In Section 4, we will explore the various types of T cells and their specific functions, including CD4+ T helper cells, CD8+ cytotoxic T cells, regulatory T cells, and memory T cells. Section 5 will examine the roles of T cells in immune responses, focusing on their contributions to viral and bacterial infections, as well as their potential in cancer immunotherapy. Section 6 will address the involvement of T cells in autoimmune diseases, discussing the mechanisms underlying autoimmune responses and potential therapeutic approaches targeting T cells. Finally, Section 7 will summarize the key findings and implications of T cell research for future therapeutic strategies.

By synthesizing current knowledge on T cell biology and their multifaceted roles in health and disease, this review aims to enhance our understanding of the immune system and provide insights that could inform the development of novel immunotherapies and vaccines. The elucidation of T cell functions not only contributes to basic immunological research but also holds promise for addressing pressing health challenges posed by infectious diseases, cancer, and autoimmune disorders [8][9].

2 T Cell Development and Differentiation ​

2.1 Origin and Maturation of T Cells ​

T cells play a crucial role in the immune response, serving as essential mediators of adaptive immunity. They are responsible for coordinating various aspects of the immune response against pathogens, allergens, and tumors, maintaining immune homeostasis throughout an individual's life. The development and differentiation of T cells occur primarily in the thymus, where they undergo a series of maturation processes that are vital for their functionality.

The origin of T cells begins in the bone marrow, where hematopoietic stem cells differentiate into common lymphoid progenitors. These progenitors migrate to the thymus, where they undergo a complex maturation process. During this process, T cells express specific markers and undergo selection processes to ensure that they can effectively recognize foreign antigens while remaining tolerant to self-antigens. This selection is critical to prevent autoimmunity.

T cell development is characterized by several key stages, including the double-negative (DN), double-positive (DP), and single-positive (SP) stages. In the DN stage, T cells lack both CD4 and CD8 co-receptors and undergo rearrangement of their T cell receptor (TCR) genes. Successful rearrangement leads to the expression of a TCR, at which point T cells become double-positive, expressing both CD4 and CD8. During this stage, they are subjected to positive and negative selection processes. Positive selection ensures that T cells can recognize self-MHC molecules, while negative selection eliminates T cells that bind too strongly to self-antigens, thus maintaining self-tolerance.

Following successful selection, T cells differentiate into various subsets, including CD4+ helper T cells and CD8+ cytotoxic T cells. CD4+ T cells play a vital role in orchestrating the immune response by activating other immune cells, including B cells and macrophages, through the secretion of cytokines. In contrast, CD8+ T cells are primarily responsible for directly killing infected or malignant cells. The differentiation of these subsets is influenced by the cytokine environment and the specific antigens they encounter, leading to a diverse array of T cell functions tailored to combat different types of pathogens or tumors.

Additionally, T cells exhibit remarkable plasticity and heterogeneity in their responses. This allows them to adapt to various immune challenges effectively. T cell communication, through direct cell-to-cell interactions and the release of cytokines, is crucial for coordinating a robust immune response. Faults in this intercellular communication can lead to immunopathology or autoimmunity, emphasizing the importance of T cell maturation and differentiation in maintaining immune balance.

In summary, T cells originate from bone marrow progenitors, mature in the thymus through a series of well-defined stages, and differentiate into functional subsets that are essential for effective immune responses. Their development is tightly regulated to ensure both the efficacy of the immune response and the prevention of autoimmunity, highlighting their critical role in the immune system [1][3][5].

2.2 Selection Processes in the Thymus ​

T cells play a critical role in various immune processes, including antigen response, tumor immunity, inflammation, and the maintenance of self-tolerance. The development of T cells occurs primarily in the thymus, where progenitor cells migrate from the bone marrow and undergo a series of complex processes that ensure the generation of a diverse and functional T cell repertoire. This development is tightly regulated and includes several key stages: T cell-lineage commitment, proliferation, T cell receptor (TCR) rearrangement, and thymic selection, which consists of both positive and negative selection processes [10].

During T cell development, progenitors encounter a specialized microenvironment within the thymus, composed of various cell types such as thymic epithelial cells (TECs), dendritic cells (DCs), macrophages, and B cells. These cells provide essential signals that guide the differentiation and selection of T cells. Positive selection occurs in the thymic cortex, where T cells that can moderately recognize self-MHC molecules are selected for survival, ensuring that they can respond to foreign antigens. In contrast, negative selection occurs in the thymic medulla, where T cells that strongly react to self-antigens are eliminated to prevent autoimmunity [[pmid:35464404],[pmid:37464188]].

The intricate process of selection is crucial for producing T cells that are not only effective in recognizing non-self antigens but also tolerant to self, thus preventing autoimmune reactions. Recent studies have highlighted the importance of the affinity between TCRs and self-peptide-MHC complexes in determining T cell fate during these selection processes [11]. Moreover, the thymic microenvironment facilitates the generation of regulatory T cells (Tregs) from self-reactive thymocytes, further contributing to immune tolerance [10].

The thymic selection process is not merely a passive filtering system but an active and dynamic process that shapes the T cell repertoire. The unique antigen-presentation capabilities of thymic cells ensure that developing T cells are exposed to a wide range of self-antigens, which is essential for establishing a self-tolerant and functional T cell pool [12]. Furthermore, various factors, including signaling pathways and the interactions among thymic stromal cells, play a pivotal role in the successful development and selection of T cells [13].

In summary, T cells are essential for orchestrating immune responses, and their development and differentiation in the thymus involve complex selection processes that ensure the generation of a functional, diverse, and self-tolerant T cell repertoire. These processes are critical for maintaining immune homeostasis and preventing autoimmune diseases.

3 Mechanisms of T Cell Activation ​

3.1 Antigen Presentation and Recognition ​

T cells are integral components of the adaptive immune response, primarily responsible for recognizing and responding to specific antigens presented by antigen-presenting cells (APCs). The activation of T cells is a multifaceted process that involves the recognition of antigens through their T cell receptors (TCRs), which is essential for the initiation of effective immune responses against pathogens.

The T cell activation process begins with the recognition of peptide antigens that are presented by major histocompatibility complex (MHC) molecules on the surface of APCs. T cells require two signals for activation: the first is the specific recognition of the antigen-MHC complex by the TCR, while the second is a co-stimulatory signal provided by the interaction of additional surface molecules on T cells and APCs. This two-signal model is crucial for preventing inappropriate activation of T cells, which could lead to autoimmunity (Cookson et al., 2001; Liu et al., 2021).

Once activated, T cells proliferate and differentiate into various effector cells, including cytotoxic T cells and helper T cells, which play distinct roles in the immune response. Cytotoxic T cells (CD8+ T cells) are primarily involved in directly killing infected or malignant cells, while helper T cells (CD4+ T cells) assist in orchestrating the immune response by secreting cytokines that modulate the activity of other immune cells (Pettmann et al., 2018; Park and Kim, 2018).

The mechanisms of T cell activation also involve intricate signaling pathways that are initiated upon TCR engagement. These pathways lead to the activation of transcription factors, which are essential for the expression of genes involved in T cell proliferation and differentiation. Recent advancements in imaging techniques have provided insights into the physical interactions at the immunological synapse, where TCRs form microclusters that facilitate efficient signaling (Pettmann et al., 2018). Additionally, the mechanical properties of the TCR-pMHC interaction, such as bond lifetimes and force regulation, are increasingly recognized as important factors influencing T cell activation outcomes (Liu et al., 2021).

In summary, T cells play a pivotal role in the immune response through their ability to recognize specific antigens presented by MHC molecules, leading to their activation and subsequent differentiation into various effector functions. This process is tightly regulated and involves complex interactions and signaling pathways that ensure an appropriate immune response to pathogens while maintaining self-tolerance. Understanding these mechanisms is crucial for the development of effective vaccines and immunotherapies.

3.2 Co-stimulatory Signals and Cytokine Environment ​

T cells play a crucial role in the immune response, acting as master regulators that coordinate the activities of various immune cells, including B cells, macrophages, and natural killer (NK) cells. Their effective functioning relies on the integration of multiple stimuli from the surrounding microenvironment, which necessitates finely tuned signaling compartmentalization within dynamic platforms. This compartmentalization is essential for T cells to respond efficiently to distinct triggers during activation and effector functions[14].

The activation of T cells primarily occurs through the engagement of the T cell receptor (TCR) with specific antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells (APCs). This engagement is not sufficient on its own; it requires additional co-stimulatory signals, typically provided by interactions between co-stimulatory molecules on T cells (such as CD28) and their ligands on APCs. The presence of these co-stimulatory signals is critical for T cell activation, proliferation, and differentiation into effector and memory cells[15].

Cytokines also play a pivotal role in T cell activation and functionality. They serve as signaling molecules that can significantly influence the behavior of T cells during immune responses. The cytokine milieu at the time of T cell activation affects not only the magnitude of the response but also the differentiation of T cells into various subsets, such as effector and memory T cells. For instance, certain cytokines can induce antigen-nonspecific activation of CD8(+) T lymphocytes, leading to their expansion and effector functions even in the absence of TCR signaling, particularly under conditions like lymphopenia[16].

Furthermore, the balance of cytokines, including pro-inflammatory and anti-inflammatory signals, is crucial for maintaining immune homeostasis and preventing immunopathology. The complex interplay between different cytokines can dictate the outcome of T cell responses, determining whether the response is protective or harmful[17].

In addition to biochemical cues, mechanical cues from the microenvironment are also significant in regulating T cell responses. The immune synapse, where T cells interact with APCs, contains force-sensitive receptors that can convert mechanical signals into biochemical responses, further influencing T cell activation and function[18].

Overall, the activation of T cells and their subsequent immune responses are orchestrated through a combination of TCR engagement, co-stimulatory signals, and the surrounding cytokine environment, which together ensure a robust and regulated immune response. Understanding these mechanisms is essential for developing therapeutic strategies to enhance T cell responses in various clinical settings, including cancer immunotherapy and autoimmune diseases.

4 Types of T Cells and Their Functions ​

4.1 CD4+ T Helper Cells ​

CD4+ T helper (Th) cells are pivotal in orchestrating the adaptive immune response, primarily by providing help to B cells and cytotoxic T cells, as well as by secreting various cytokines that mediate protective responses against a diverse array of pathogenic microorganisms. The functional heterogeneity of CD4+ T cells is a key aspect of their role in immune responses, with distinct subsets such as Th1, Th2, Th17, and regulatory T cells (Tregs) fulfilling specialized functions in response to different pathogens and environmental signals.

The differentiation of naive CD4+ T cells into specific subsets is influenced by the cytokine milieu and the nature of the antigen encountered. For instance, Th1 cells are primarily involved in responses against intracellular pathogens, such as viruses and certain bacteria, and are characterized by their production of interferon-gamma (IFN-γ), which activates macrophages and enhances the cytotoxic functions of CD8+ T cells. In contrast, Th2 cells are essential for combating extracellular parasites and allergens, producing cytokines like interleukin-4 (IL-4) that promote B cell activation and antibody production, particularly IgE responses associated with allergic reactions[19][20].

Th17 cells, another subset, play a crucial role in defending against extracellular bacteria and fungi, primarily through the production of IL-17, which recruits neutrophils to sites of infection and enhances barrier functions in epithelial tissues. Regulatory T cells, on the other hand, are essential for maintaining immune tolerance and preventing autoimmunity by suppressing excessive immune responses[21][22].

The plasticity of CD4+ T cells is also noteworthy, as these cells can adapt their functions based on the signals received from the environment. For example, central memory T cells can exhibit diverse functional properties upon re-encountering antigens, which is critical for the efficiency of secondary immune responses[23][24]. This adaptability is particularly relevant in chronic infections and cancer, where the immune landscape is often altered[4].

Recent advances have highlighted the importance of CD4+ T cells in vaccine responses and chronic infections, such as HIV, where their ability to support B cell activation and produce neutralizing antibodies is crucial for effective immunity[25]. The identification of specific CD4+ T cell subsets and their functional capabilities provides insights into how to enhance vaccine efficacy and develop targeted immunotherapies[26].

In summary, CD4+ T helper cells are central to the adaptive immune response, with their diverse subsets tailored to combat various pathogens and maintain immune homeostasis. Their ability to differentiate into functionally distinct populations, coupled with their plasticity, underscores their significance in both protective immunity and the pathogenesis of autoimmune diseases[27][28].

4.2 CD8+ Cytotoxic T Cells ​

CD8+ T cells, also known as cytotoxic T lymphocytes (CTLs), are a pivotal component of the adaptive immune system, primarily responsible for the elimination of virus-infected cells and tumor cells. These cells recognize antigens presented by major histocompatibility complex (MHC) class I molecules on the surface of infected or malignant cells, leading to their activation and subsequent cytotoxic action.

Upon activation, CD8+ T cells proliferate and differentiate into effector cells capable of executing their cytotoxic functions. They release various cytokines, including interferon-gamma (IFN-γ), which not only enhances their own cytotoxic capabilities but also activates other immune cells, such as macrophages, to improve the overall immune response against pathogens [29]. This process is critical during primary infections, where CTLs play a major role in clearing viral pathogens through their ability to lyse infected cells and produce inflammatory cytokines [29].

In addition to their cytotoxic functions, CD8+ T cells can also exhibit helper-like activities. Some subsets of CD8+ T cells express CD40L, which allows them to activate antigen-presenting cells (APCs) and support CD4+ T cell responses, thus broadening the scope of the immune response [30]. This versatility is significant in orchestrating a robust immune defense, especially in the context of complex infections and tumor immunology.

However, CD8+ T cells can undergo a process known as "exhaustion" during chronic infections or in the tumor microenvironment, where they lose their functional capacity to produce cytokines and exhibit cytotoxicity [31]. This phenomenon is characterized by persistent antigen exposure, leading to a progressive decline in their effectiveness, which poses a challenge for immunotherapy strategies aimed at reinvigorating these cells [31].

The differentiation and functional capabilities of CD8+ T cells are influenced by various factors, including the strength of the antigenic stimulus, the presence of co-stimulatory signals, and the cytokine milieu [32]. For instance, the presence of IL-21 can enhance the effector functions of CD8+ T cells by inducing the expression of IL-1 receptors, which further augments their cytokine production and cytotoxic granule release [33].

In summary, CD8+ T cells are essential for effective immune responses against intracellular pathogens and tumors, combining cytotoxic activity with regulatory and helper functions. Their ability to adapt to different immune challenges underscores their importance in both protective immunity and the development of immunotherapeutic strategies for various diseases, including cancer and chronic infections [34]. Understanding the diverse roles and mechanisms of CD8+ T cells will be crucial for enhancing vaccine efficacy and developing novel immunotherapies.

4.3 Regulatory T Cells ​

Regulatory T cells (Tregs), a subset of CD4(+) T lymphocytes, play a pivotal role in the regulation of immune responses and the maintenance of immune homeostasis. Their primary function is to suppress excessive immune activation that could lead to tissue damage, autoimmunity, and chronic inflammation. Tregs are crucial for maintaining tolerance to self-antigens and preventing autoimmune diseases, as they actively inhibit the activation and proliferation of effector T cells and other immune cells.

The mechanisms through which Tregs exert their suppressive functions include direct cell-to-cell contact, secretion of immunosuppressive cytokines (such as IL-10 and TGF-β), and modulation of dendritic cell activity. Tregs can also induce apoptosis in effector T cells, further curbing immune responses. This multifaceted approach allows Tregs to effectively regulate immune responses to various challenges, including infections, tumors, and environmental allergens [5][35][36].

In addition to their immunosuppressive functions, Tregs are also involved in promoting tissue homeostasis and repair. They adapt their functions according to the local tissue environment, which is essential for preventing inappropriate immune responses to commensal organisms and maintaining the integrity of tissue microenvironments [37][38].

Research has shown that Tregs are critical in various pathological conditions, including chronic inflammatory diseases, allergies, and cancer. For instance, in the context of gastrointestinal diseases, Tregs help modulate immune responses to gut microbiota and prevent inflammatory bowel diseases [39][40]. Furthermore, Tregs can influence the outcome of viral infections by modulating the immune response, thus playing a dual role in either facilitating pathogen persistence or contributing to protective immunity [41][42].

The therapeutic potential of Tregs has garnered significant interest in recent years. Enhancing Treg numbers or functions could provide novel strategies for treating autoimmune diseases, allergies, and even cancer by restoring immune tolerance and preventing pathological immune responses [37][43].

Overall, Tregs are integral to the immune system, serving as a critical balance between effective immune defense and the prevention of harmful inflammatory responses. Understanding their biology and mechanisms is essential for developing targeted immunotherapies aimed at modulating immune responses in various clinical settings.

4.4 Memory T Cells ​

Memory T cells are a critical component of the adaptive immune response, providing long-lasting protection against previously encountered pathogens. They are generated following an initial encounter with an antigen and persist throughout an individual's life, enabling rapid and robust functional responses upon re-exposure to the same antigen. Memory T cells can be classified into different subsets based on their functional properties and migratory patterns, which are essential for their roles in both protective immunity and potential immunopathology.

There are two primary types of memory T cells: central memory T cells (T_CM) and effector memory T cells (T_EM). T_CM cells are predominantly found in lymphoid organs and are characterized by their ability to proliferate and differentiate into effector cells upon re-encounter with the antigen. In contrast, T_EM cells are primarily located in peripheral tissues and are poised for immediate effector functions, allowing for rapid responses to infections [44].

Memory T cells also exhibit a high frequency and elevated activation state, which enables them to respond swiftly to antigenic challenges. This capability is crucial for preventing the re-emergence of low-grade persistent pathogens and providing protection upon re-exposure to pathogens [45]. The memory T cell compartment is notably heterogeneous, with distinct subsets that dominate in different tissue environments, including lymphoid and non-lymphoid tissues [6].

In addition to their protective roles, memory T cells can contribute to autoimmune diseases and allograft rejection. The pathways that regulate memory immune responses remain largely undefined, making it challenging to develop effective immunomodulation strategies [6]. However, understanding the mechanisms governing memory T cell generation and recall is essential for designing effective vaccines and immunotherapies [46].

Tissue-resident memory T cells (Trm) represent a specialized subset that remains permanently in tissues, playing a crucial role in local immune surveillance and rapid response to pathogens [47]. These cells are particularly important in mucosal tissues, where they provide immediate protection against re-infection and are involved in the pathogenesis of various immunological diseases [48].

Overall, memory T cells are fundamental to the immune system's ability to remember and respond effectively to previously encountered pathogens, highlighting their importance in both protective immunity and the potential for immune dysregulation in various diseases [49][50]. Understanding their roles and mechanisms is vital for advancing therapeutic strategies against infections, autoimmune disorders, and in the context of vaccination [51][52].

5 T Cells in Immune Responses ​

5.1 Role in Viral Infections ​

T cells play a crucial role in the immune response against viral infections, acting as key components of adaptive immunity. They are essential for the recognition and elimination of virus-infected cells, and their responses can be categorized into different subsets, including CD4+ helper T cells and CD8+ cytotoxic T cells, each serving distinct functions in viral control.

During viral infections, T cells undergo activation upon recognizing specific viral antigens presented by Major Histocompatibility Complex (MHC) molecules on infected cells. This recognition leads to clonal expansion and differentiation into effector T cells capable of targeting and destroying infected cells. CD8+ T cells are particularly important for directly killing infected cells, while CD4+ T cells provide help to other immune cells, enhancing the overall immune response (Norris and Rosenberg, 2002; Pallett et al., 2019).

In chronic viral infections, such as those caused by hepatitis B and C viruses (HBV and HCV), T cells often exhibit a state known as "exhaustion," characterized by reduced functionality and impaired ability to control the virus. This exhaustion is driven by chronic antigenic stimulation and an unfavorable microenvironment, which alters T cell metabolism and impairs their effector functions (Zheng et al., 2022; Jung and Pape, 2002). Understanding these metabolic alterations is vital for developing immunotherapeutic strategies aimed at revitalizing T cell responses in chronic infections.

Moreover, T cell responses can be influenced by various factors, including the presence of regulatory T cells (Tregs) that can suppress effector T cell activity, potentially contributing to viral persistence and disease progression (Miroux et al., 2010). In the context of vaccines, the induction of robust T cell responses is essential for providing long-term immunity, especially against viruses that exhibit high variability, such as influenza (Jansen et al., 2019).

The unique microenvironment of the liver, for instance, can modulate T cell functions during hepatotropic viral infections, highlighting the complexity of T cell interactions in different tissue contexts (Lopez-Scarim et al., 2023). Additionally, recent studies have shown that specific T cell subsets, such as γδ T cells, play a significant role in the immune response to viral infections by directly presenting antigens and promoting CD8+ T cell activation (Dai et al., 2021).

In summary, T cells are pivotal in orchestrating immune responses against viral infections, with their functions shaped by the nature of the infection, the local immune environment, and the presence of regulatory mechanisms. Enhancing our understanding of T cell dynamics and their metabolic profiles during viral infections is critical for developing effective vaccines and therapeutic interventions.

5.2 Role in Bacterial Infections ​

T cells play a critical role in the immune response to bacterial infections, orchestrating both adaptive and innate immune mechanisms. Various T cell subsets contribute uniquely to the host's defense against a range of bacterial pathogens.

One of the significant T cell subsets involved in bacterial infections is the γδ T cells. These unconventional T cells, while constituting a small fraction of the lymphocyte population in circulation, become significantly expanded in mucosal and epithelial tissues during bacterial infections. γδ T cells are activated in response to bacterial challenges and can produce pro-inflammatory cytokines that recruit neutrophils, thus aiding in the clearance of infections. They also help modulate the immune response to prevent excessive inflammation, highlighting their dual role in both promoting immunity and protecting against tissue damage [53].

Another critical subset is the CD4(+) T helper cells, which can be further classified into various functional groups such as Th1, Th2, and regulatory T (Treg) cells. Th1 cells are particularly important in the context of intracellular bacterial infections like those caused by Mycobacterium tuberculosis. They produce cytokines such as IFN-γ and TNF-α, which are crucial for activating macrophages and enhancing their ability to kill intracellular pathogens [54]. Conversely, Treg cells play a complex role by maintaining immune homeostasis and preventing excessive inflammatory responses, which can be detrimental [55].

In infections like those caused by Staphylococcus aureus, T cells, particularly γδ T cells, have been shown to produce IL-17, which is essential for neutrophil recruitment and effective immune responses against skin infections [56]. This cytokine's production is dependent on various signals, including IL-1 and TLR2, underscoring the intricate signaling networks involved in T cell activation during bacterial infections.

Furthermore, the role of CD8(+) T cells in bacterial infections is increasingly recognized. Although traditionally associated with viral infections, CD8(+) T cells also contribute to protection against bacteria by directly killing infected cells and producing cytokines [54]. Their functional profile can include polyfunctionality, which is associated with better protection against pathogens [57].

In summary, T cells are pivotal in mediating immune responses to bacterial infections through their diverse subsets and functional capabilities. They contribute to both the clearance of pathogens and the regulation of inflammatory responses, which are crucial for maintaining tissue integrity and preventing immunopathology. Understanding the specific roles and mechanisms of different T cell populations can provide insights into developing targeted immunotherapies and vaccines against bacterial infections.

5.3 T Cells in Cancer Immunity ​

T cells play a pivotal role in orchestrating immune responses against cancer and other diseases. They are primarily categorized into two main subsets: CD4+ T helper cells and CD8+ cytotoxic T cells, each with distinct functions in the immune response.

CD4+ T cells, often referred to as helper T cells, are crucial for activating and enhancing the activity of other immune cells, including B cells, macrophages, and cytotoxic T cells. They recognize antigens presented by MHC class II molecules and release cytokines that orchestrate the immune response. These cells can also differentiate into various subsets, such as Th1, Th2, Th17, and regulatory T cells (Tregs), each playing unique roles in modulating immune responses. For instance, Th1 cells are primarily involved in cellular immunity and can enhance the activation of cytotoxic T lymphocytes (CTLs), which are essential for anti-tumor immunity [58].

On the other hand, CD8+ T cells, known as cytotoxic T cells, directly kill cancer cells and infected cells. They recognize antigens presented by MHC class I molecules and, upon activation, release cytotoxic granules containing perforins and granzymes that induce apoptosis in target cells [4]. The activation of CD8+ T cells is also dependent on signals from CD4+ T cells, emphasizing the cooperative nature of T cell interactions in the immune response [59].

T cells are integral to the success of cancer immunotherapy. They can be harnessed to specifically target and eliminate tumor cells, as seen in various therapeutic strategies such as CAR T cell therapy and checkpoint inhibitors [60]. However, the tumor microenvironment often imposes significant challenges, leading to T cell exhaustion, a state characterized by reduced functionality and increased expression of inhibitory receptors [61]. This phenomenon is critical in understanding why some tumors evade immune surveillance and how therapies can be designed to rejuvenate T cell responses [62].

Furthermore, the metabolic state of T cells is crucial for their function. T cells undergo metabolic reprogramming in response to environmental cues, which can influence their survival, proliferation, and effector functions [63]. Tumors can exploit these metabolic pathways to suppress T cell activity, making it essential to consider metabolic interventions alongside immunotherapy [64].

Recent research also highlights the importance of T cell subsets in different tumor types, indicating that the composition and state of tumor-infiltrating T cells can provide insights into patient prognosis and potential therapeutic targets [65]. Understanding the heterogeneity of T cells in the tumor microenvironment is critical for developing effective immunotherapies that can overcome barriers to T cell activation and function [66].

In summary, T cells are central to the immune response against cancer, with their roles ranging from direct cytotoxic activity to orchestrating broader immune responses. Ongoing research into T cell biology, their interactions within the tumor microenvironment, and their metabolic requirements is vital for advancing cancer immunotherapy and improving patient outcomes.

6 T Cells and Autoimmunity ​

6.1 Mechanisms of Autoimmune Responses ​

T cells are a pivotal component of the adaptive immune response, primarily functioning to recognize and respond to specific antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. Their activation is essential for initiating immune responses against pathogens, as well as for maintaining immune homeostasis. T cells can be broadly categorized into various subsets, including CD4⁺ T helper (Th) cells and CD8⁺ cytotoxic T cells, each playing distinct roles in immune regulation and response.

In the context of autoimmune diseases, T cells can contribute to pathologic immune responses when the mechanisms of self-tolerance break down. T cells recognize self-antigens, leading to the activation of autoreactive T cells that can cause tissue damage. This process is influenced by various factors, including the balance between effector T cells and regulatory T cells (Tregs). For instance, a failure in the regulatory mechanisms that control T cell activation can lead to an increased number of autoreactive T cells, contributing to the development of autoimmune diseases [67].

The role of T cells in autoimmunity is multifaceted. Activated T cells can produce a range of cytokines that mediate inflammation and recruit additional immune cells to sites of tissue damage. For example, in multiple sclerosis (MS), activated T cells specific for myelin components infiltrate the central nervous system (CNS), leading to demyelination and neuroinflammation [68]. Similarly, in conditions such as rheumatoid arthritis, T cells can promote inflammation and joint damage through the production of pro-inflammatory cytokines [69].

Moreover, T cell receptor (TCR) specificity plays a critical role in the initiation of autoimmune responses. Advances in understanding TCR usage have revealed that certain TCRs are preferentially involved in autoimmune diseases, providing insights into potential therapeutic targets [70]. The dysregulation of T cell signaling pathways, often due to post-translational modifications, can further exacerbate autoimmune responses by altering T cell activation and differentiation [71].

In summary, T cells are central to both the protective immune response and the pathogenesis of autoimmune diseases. Their ability to distinguish between self and non-self is crucial, and any disruption in this balance can lead to inappropriate activation of autoreactive T cells, resulting in tissue damage and chronic inflammation. Understanding the mechanisms underlying T cell activation, differentiation, and regulation is essential for developing targeted therapies for autoimmune disorders.

6.2 Therapeutic Approaches Targeting T Cells ​

T cells play a crucial role in orchestrating the immune response, functioning as key mediators in the adaptive immune system. They are primarily responsible for recognizing and eliminating abnormal or malignant cells, including pathogens and cancer cells, through various mechanisms. The two main subtypes of T cells, CD4+ T helper cells and CD8+ cytotoxic T cells, each have distinct but complementary roles in the immune response.

CD4+ T cells are essential for activating and enhancing the immune response. They interact with antigen-presenting cells (APCs) and help orchestrate the activation of other immune cells, including B cells and macrophages. This subset of T cells is restricted to recognizing antigens presented by MHC class II molecules, which are primarily expressed on professional APCs. In contrast, CD8+ T cells, often referred to as cytotoxic T cells, directly target and kill infected or malignant cells. They recognize antigens presented by MHC class I molecules, which are found on nearly all nucleated cells, allowing them to monitor for abnormal cellular changes, such as those occurring in cancer or viral infections [4].

In addition to their roles in pathogen clearance, T cells are also involved in maintaining immune tolerance to self-antigens, thereby preventing autoimmunity. Regulatory T cells (Tregs), a subset of CD4+ T cells characterized by the expression of CD25, play a critical role in modulating immune responses to prevent excessive inflammation and tissue damage. They achieve this by suppressing the activity of effector T cells and other immune components, ensuring that the immune response is appropriately calibrated [5].

The therapeutic targeting of T cells has emerged as a promising strategy in various clinical contexts, particularly in cancer immunotherapy and autoimmune diseases. For instance, in cancer treatment, strategies such as CAR T cell therapy are designed to enhance the cytotoxic activity of T cells against tumor cells. These approaches harness the ability of T cells to recognize and eliminate cancer cells, often leading to significant clinical responses [9].

Conversely, in the context of autoimmune diseases, where the immune system mistakenly targets self-tissues, therapeutic strategies may focus on enhancing Treg function or depleting pathogenic effector T cells. By restoring the balance of T cell subsets, these therapies aim to reduce autoimmune pathology and improve patient outcomes [72].

In summary, T cells are pivotal in shaping the immune response, contributing to both protective immunity and the maintenance of self-tolerance. Their diverse functions and interactions with other immune components make them central targets for therapeutic interventions aimed at enhancing immune responses in infections and cancers, as well as suppressing harmful autoimmune reactions. Understanding the mechanisms of T cell activation, differentiation, and regulation will be essential for the development of effective immunotherapies [5][8][9].

7 Conclusion ​

This review highlights the multifaceted roles of T cells in immune responses, emphasizing their critical functions in both protective immunity and the pathogenesis of diseases such as cancer and autoimmune disorders. T cells, originating from hematopoietic stem cells and maturing in the thymus, undergo rigorous selection processes that ensure the development of a diverse and functional repertoire capable of distinguishing self from non-self. The review underscores the importance of CD4+ T helper cells in orchestrating immune responses, CD8+ cytotoxic T cells in eliminating infected and malignant cells, regulatory T cells in maintaining immune tolerance, and memory T cells in providing long-lasting immunity. The intricate mechanisms of T cell activation, influenced by antigen presentation, co-stimulatory signals, and the cytokine environment, are crucial for their effective functioning. Current research indicates that T cell dysfunction, particularly in chronic infections and tumors, poses significant challenges for immunotherapy. Future studies should focus on elucidating the metabolic and signaling pathways governing T cell responses, which could lead to innovative therapeutic strategies for enhancing T cell efficacy in various clinical settings. By advancing our understanding of T cell biology, we can develop targeted immunotherapies that address pressing health challenges posed by infectious diseases, cancer, and autoimmune disorders.

References ​

  • [1] Brahma V Kumar;Thomas J Connors;Donna L Farber. Human T Cell Development, Localization, and Function throughout Life.. Immunity(IF=26.3). 2018. PMID:29466753. DOI: 10.1016/j.immuni.2018.01.007.
  • [2] Rayene Benlaribi;Qiao Gou;Hiroyuki Takaba. Thymic self-antigen expression for immune tolerance and surveillance.. Inflammation and regeneration(IF=6.6). 2022. PMID:36056452. DOI: 10.1186/s41232-022-00211-z.
  • [3] Rafeul Alam;Magdalena Gorska. 3. Lymphocytes.. The Journal of allergy and clinical immunology(IF=11.2). 2003. PMID:12592294. DOI: 10.1067/mai.2003.121.
  • [4] Anisha Singha Deo; Shrijana;Sruthika S U;Shreya Karun;Kashish Bisaria;Koustav Sarkar. Participation of T cells in generating immune protection against cancers.. Pathology, research and practice(IF=3.2). 2024. PMID:39180801. DOI: 10.1016/j.prp.2024.155534.
  • [5] Geordie Rudge;Paul A Gleeson;Ian R van Driel. Control of immune responses by immunoregulatory T cells.. Archivum immunologiae et therapiae experimentalis(IF=3.9). 2006. PMID:17122882. DOI: 10.1007/s00005-006-0045-8.
  • [6] Modesta P Ndejembi;Anita L Tang;Donna L Farber. Reshaping the past: Strategies for modulating T-cell memory immune responses.. Clinical immunology (Orlando, Fla.)(IF=3.8). 2007. PMID:16916619. DOI: 10.1016/j.clim.2006.06.012.
  • [7] Joon Seok Park;Ji Hyung Kim. Role of non-classical T cells in skin immunity.. Molecular immunology(IF=3.0). 2018. PMID:30343117. DOI: 10.1016/j.molimm.2018.09.024.
  • [8] Janna R Shapiro;Mario Corrado;Julie Perry;Tania H Watts;Shelly Bolotin. The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.. Human vaccines & immunotherapeutics(IF=3.5). 2024. PMID:39205626. DOI: 10.1080/21645515.2024.2395679.
  • [9] Ziyu Liu;Jiajun Zhou;Shihui Wu;Zhihong Chen;Shuhong Wu;Ling Chen;Xiao Zhu;Zesong Li. Why Treg should be the focus of cancer immunotherapy: The latest thought.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie(IF=7.5). 2023. PMID:37806087. DOI: 10.1016/j.biopha.2023.115142.
  • [10] Hui Yu;Wenyong Yang;Min Cao;Qingqiang Lei;Renbin Yuan;He Xu;Yuqian Cui;Xuerui Chen;Xu Su;Hui Zhuo;Liangbin Lin. Mechanism study of ubiquitination in T cell development and autoimmune disease.. Frontiers in immunology(IF=5.9). 2024. PMID:38562929. DOI: 10.3389/fimmu.2024.1359933.
  • [11] Kenta Kondo;Izumi Ohigashi;Yousuke Takahama. Thymus machinery for T-cell selection.. International immunology(IF=3.2). 2019. PMID:30476234. DOI: 10.1093/intimm/dxy081.
  • [12] K Maude Ashby;Kristin A Hogquist. A guide to thymic selection of T cells.. Nature reviews. Immunology(IF=60.9). 2024. PMID:37464188. DOI: 10.1038/s41577-023-00911-8.
  • [13] Valentin P Shichkin;Mariastefania Antica. Key Factors for Thymic Function and Development.. Frontiers in immunology(IF=5.9). 2022. PMID:35844535. DOI: 10.3389/fimmu.2022.926516.
  • [14] Barbara Molon;Cristina Liboni;Antonella Viola. CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse.. Frontiers in immunology(IF=5.9). 2022. PMID:35983040. DOI: 10.3389/fimmu.2022.938004.
  • [15] Robert J Salmond;Andrew Filby;Ihjaaz Qureshi;Stefano Caserta;Rose Zamoyska. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance.. Immunological reviews(IF=8.3). 2009. PMID:19290918. DOI: 10.1111/j.1600-065X.2008.00745.x.
  • [16] Sheela Ramanathan;Julien Gagnon;Subburaj Ilangumaran. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.. Archivum immunologiae et therapiae experimentalis(IF=3.9). 2008. PMID:18836862. DOI: 10.1007/s00005-008-0033-2.
  • [17] Jose A Chabalgoity;Adriana Baz;Analía Rial;Sofía Grille. The relevance of cytokines for development of protective immunity and rational design of vaccines.. Cytokine & growth factor reviews(IF=11.8). 2007. PMID:17347024. DOI: 10.1016/j.cytogfr.2007.01.016.
  • [18] Lingzhu Zhao;Guoqing Zhao;Jinteng Feng;Zheng Zhang;Jiayu Zhang;Hui Guo;Min Lin. T Cell engineering for cancer immunotherapy by manipulating mechanosensitive force-bearing receptors.. Frontiers in bioengineering and biotechnology(IF=4.8). 2023. PMID:37560540. DOI: 10.3389/fbioe.2023.1220074.
  • [19] Federica Sallusto. Heterogeneity of Human CD4(+) T Cells Against Microbes.. Annual review of immunology(IF=33.3). 2016. PMID:27168241. DOI: 10.1146/annurev-immunol-032414-112056.
  • [20] Jeffrey D Ahlers;Igor M Belyakov. Molecular pathways regulating CD4(+) T cell differentiation, anergy and memory with implications for vaccines.. Trends in molecular medicine(IF=13.8). 2010. PMID:20739220. DOI: 10.1016/j.molmed.2010.07.007.
  • [21] Jinfang Zhu;William E Paul. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.. Immunological reviews(IF=8.3). 2010. PMID:20969597. DOI: 10.1111/j.1600-065X.2010.00951.x.
  • [22] Jens Geginat;Moira Paroni;Stefano Maglie;Johanna Sophie Alfen;Ilko Kastirr;Paola Gruarin;Marco De Simone;Massimiliano Pagani;Sergio Abrignani. Plasticity of human CD4 T cell subsets.. Frontiers in immunology(IF=5.9). 2014. PMID:25566245. DOI: 10.3389/fimmu.2014.00630.
  • [23] Brigitta Stockinger;Christine Bourgeois;George Kassiotis. CD4+ memory T cells: functional differentiation and homeostasis.. Immunological reviews(IF=8.3). 2006. PMID:16824115. DOI: 10.1111/j.0105-2896.2006.00381.x.
  • [24] Jérôme Kervevan;Lisa A Chakrabarti. Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.. International journal of molecular sciences(IF=4.9). 2021. PMID:33430234. DOI: 10.3390/ijms22020523.
  • [25] Kristen Cohen;Marcus Altfeld;Galit Alter;Leonidas Stamatatos. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection.. Journal of virology(IF=3.8). 2014. PMID:25210168. DOI: 10.1128/JVI.02186-14.
  • [26] Laura Cook;C Mee Ling Munier. Help is on the way: critical roles of CD4+ T cells in infection and vaccination.. Immunology and cell biology(IF=3.0). 2023. PMID:37393192. DOI: 10.1111/imcb.12662.
  • [27] Itay Raphael;Rachel R Joern;Thomas G Forsthuber. Memory CD4+ T Cells in Immunity and Autoimmune Diseases.. Cells(IF=5.2). 2020. PMID:32106536. DOI: 10.3390/cells9030531.
  • [28] Richard Kennedy;Esteban Celis. Multiple roles for CD4+ T cells in anti-tumor immune responses.. Immunological reviews(IF=8.3). 2008. PMID:18363998. DOI: 10.1111/j.1600-065X.2008.00616.x.
  • [29] Benjamin J Marsland;Nicole Schmitz;Manfred Kopf. IL-4Ralpha signaling is important for CD8+ T cell cytotoxicity in the absence of CD4+ T cell help.. European journal of immunology(IF=3.7). 2005. PMID:15816016. DOI: 10.1002/eji.200425768.
  • [30] Marco Frentsch;Regina Stark;Nadine Matzmohr;Sarah Meier;Sibel Durlanik;Axel R Schulz;Ulrik Stervbo;Karsten Jürchott;Friedemann Gebhardt;Guido Heine;Morgan A Reuter;Michael R Betts;Dirk Busch;Andreas Thiel. CD40L expression permits CD8+ T cells to execute immunologic helper functions.. Blood(IF=23.1). 2013. PMID:23719298. DOI: 10.1182/blood-2013-02-483586.
  • [31] Jenna L Collier;Sarah A Weiss;Kristen E Pauken;Debattama R Sen;Arlene H Sharpe. Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity.. Nature immunology(IF=27.6). 2021. PMID:34140679. DOI: 10.1038/s41590-021-00949-7.
  • [32] Hans-Willi Mittrücker;Alexander Visekruna;Magdalena Huber. Heterogeneity in the differentiation and function of CD8⁺ T cells.. Archivum immunologiae et therapiae experimentalis(IF=3.9). 2014. PMID:24879097. DOI: 10.1007/s00005-014-0293-y.
  • [33] Dong Hyun Kim;Hee Young Kim;Won-Woo Lee. Induction of Unique STAT Heterodimers by IL-21 Provokes IL-1RI Expression on CD8+ T Cells, Resulting in Enhanced IL-1β Dependent Effector Function.. Immune network(IF=4.1). 2021. PMID:34796037. DOI: 10.4110/in.2021.21.e33.
  • [34] Quynh Chau Ton Nu;Gitima Deka;Pil-Hoon Park. CD8+ T cell-based immunotherapy: Promising frontier in human diseases.. Biochemical pharmacology(IF=5.6). 2025. PMID:40179991. DOI: 10.1016/j.bcp.2025.116909.
  • [35] K E Birch;M Vukmanovic-Stejic;J R Reed;A N Akbar;M H A Rustin. The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin.. The British journal of dermatology(IF=9.6). 2005. PMID:15787808. DOI: 10.1111/j.1365-2133.2005.06476.x.
  • [36] Kingston H G Mills. Regulatory T cells: friend or foe in immunity to infection?. Nature reviews. Immunology(IF=60.9). 2004. PMID:15516964. DOI: 10.1038/nri1485.
  • [37] David F Tough;Giovanna Lombardi. Therapeutic opportunities for regulatory T-cell enhancing approaches.. Clinical and experimental immunology(IF=3.8). 2023. PMID:36807653. DOI: 10.1093/cei/uxad009.
  • [38] Oliver J Harrison;Fiona M Powrie. Regulatory T cells and immune tolerance in the intestine.. Cold Spring Harbor perspectives in biology(IF=8.4). 2013. PMID:23818502. DOI: .
  • [39] Ian R van Driel;Desmond K Y Ang. Role of regulatory T cells in gastrointestinal inflammatory disease.. Journal of gastroenterology and hepatology(IF=3.4). 2008. PMID:18289352. DOI: 10.1111/j.1440-1746.2007.05278.x.
  • [40] James D Lord. Promises and paradoxes of regulatory T cells in inflammatory bowel disease.. World journal of gastroenterology(IF=5.4). 2015. PMID:26523099. DOI: 10.3748/wjg.v21.i40.11236.
  • [41] Yoav Keynan;Catherine M Card;Paul J McLaren;Magdy R Dawood;Ken Kasper;Keith R Fowke. The role of regulatory T cells in chronic and acute viral infections.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America(IF=7.3). 2008. PMID:18444822. DOI: 10.1086/529379.
  • [42] Ana M Sanchez;Yiping Yang. The role of natural regulatory T cells in infection.. Immunologic research(IF=3.1). 2011. PMID:21116872. DOI: 10.1007/s12026-010-8176-8.
  • [43] Christian Becker;Sabine Stoll;Tobias Bopp;Edgar Schmitt;Helmut Jonuleit. Regulatory T cells: present facts and future hopes.. Medical microbiology and immunology(IF=3.0). 2006. PMID:16715254. DOI: 10.1007/s00430-006-0017-y.
  • [44] Mark T Esser;Rocio D Marchese;Lisa S Kierstead;Lynda G Tussey;Fubao Wang;Narendra Chirmule;Michael W Washabaugh. Memory T cells and vaccines.. Vaccine(IF=3.5). 2003. PMID:12531640. DOI: 10.1016/s0264-410x(02)00407-3.
  • [45] Liisa K Selin;Michael A Brehm;Yuri N Naumov;Markus Cornberg;Sung-Kwon Kim;Shalyn C Clute;Raymond M Welsh. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.. Immunological reviews(IF=8.3). 2006. PMID:16824126. DOI: 10.1111/j.0105-2896.2006.00394.x.
  • [46] Nicholas D Bushar;Donna L Farber. Recalling the year in memory T cells.. Annals of the New York Academy of Sciences(IF=4.8). 2008. PMID:19076352. DOI: 10.1196/annals.1443.015.
  • [47] Simone L Park;Laura K Mackay. Decoding Tissue-Residency: Programming and Potential of Frontline Memory T Cells.. Cold Spring Harbor perspectives in biology(IF=8.4). 2021. PMID:33753406. DOI: 10.1101/cshperspect.a037960.
  • [48] Eva-Maria Paap;Tanja M Müller;Katrin Sommer;Markus F Neurath;Sebastian Zundler. Total Recall: Intestinal TRM Cells in Health and Disease.. Frontiers in immunology(IF=5.9). 2020. PMID:33542725. DOI: 10.3389/fimmu.2020.623072.
  • [49] Nora Lam;YoonSeung Lee;Donna L Farber. A guide to adaptive immune memory.. Nature reviews. Immunology(IF=60.9). 2024. PMID:38831162. DOI: 10.1038/s41577-024-01040-6.
  • [50] Shilpi Giri;Lalit Batra. Memory Cells in Infection and Autoimmunity: Mechanisms, Functions, and Therapeutic Implications.. Vaccines(IF=3.4). 2025. PMID:40006751. DOI: 10.3390/vaccines13020205.
  • [51] Grégoire Lauvau;Marie Boutet;Tere M Williams;Shu Shien Chin;Laurent Chorro. Memory CD8(+) T Cells: Innate-Like Sensors and Orchestrators of Protection.. Trends in immunology(IF=13.9). 2016. PMID:27131432. DOI: 10.1016/j.it.2016.04.001.
  • [52] Melissa K Ward;Stephanie Aleite;Diana M Sheehan;Tan Li;Semiu O Gbadamosi;Michèle Jean-Gilles;Robert A Ladner;Mary Jo Trepka. Self-reported Nonadherence to Antiretroviral Therapy Among Miami-Dade Ryan White Program Clients During the COVID-19 Pandemic: A Cross-sectional Study.. The Journal of the Association of Nurses in AIDS Care : JANAC(IF=1.5). 2023. PMID:36607312. DOI: 10.1097/JNC.0000000000000382.
  • [53] Namya Nanda;Martin P Alphonse. From Host Defense to Metabolic Signatures: Unveiling the Role of γδ T Cells in Bacterial Infections.. Biomolecules(IF=4.8). 2024. PMID:38397462. DOI: 10.3390/biom14020225.
  • [54] Teresa Prezzemolo;Giuliana Guggino;Marco Pio La Manna;Diana Di Liberto;Francesco Dieli;Nadia Caccamo. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.. Frontiers in immunology(IF=5.9). 2014. PMID:24795723. DOI: 10.3389/fimmu.2014.00180.
  • [55] Peter McGuirk;Kingston H G Mills. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases.. Trends in immunology(IF=13.9). 2002. PMID:12200067. DOI: 10.1016/s1471-4906(02)02288-3.
  • [56] John S Cho;Eric M Pietras;Nairy C Garcia;Romela Irene Ramos;David M Farzam;Holly R Monroe;Julie E Magorien;Andrew Blauvelt;Jay K Kolls;Ambrose L Cheung;Genhong Cheng;Robert L Modlin;Lloyd S Miller. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.. The Journal of clinical investigation(IF=13.6). 2010. PMID:20364087. DOI: .
  • [57] Katalin A Wilkinson;Robert J Wilkinson. Polyfunctional T cells in human tuberculosis.. European journal of immunology(IF=3.7). 2010. PMID:20853500. DOI: 10.1002/eji.201040731.
  • [58] Kazuhiko Matsuo;Osamu Yoshie;Takashi Nakayama. Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity.. Cancers(IF=4.4). 2021. PMID:34885241. DOI: 10.3390/cancers13236132.
  • [59] Carlo Fremd;Florian Schuetz;Christof Sohn;Philipp Beckhove;Christoph Domschke. B cell-regulated immune responses in tumor models and cancer patients.. Oncoimmunology(IF=6.3). 2013. PMID:24073382. DOI: 10.4161/onci.25443.
  • [60] Kaili Zhang;Yi Zhang;Pan Xiang;Yi Wang;Yifan Li;Shuze Jiang;Yuxuan Zhang;Min Chen;Weijun Su;Xiaoling Li;Shuai Li. Advances in T Cell-Based Cancer Immunotherapy: From Fundamental Mechanisms to Clinical Prospects.. Molecular pharmaceutics(IF=4.5). 2025. PMID:40359327. DOI: 10.1021/acs.molpharmaceut.4c01502.
  • [61] Xiaoxia Chi;Shahang Luo;Peng Ye;Wei-Lun Hwang;Jong-Ho Cha;Xiuwen Yan;Wen-Hao Yang. T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications.. Frontiers in immunology(IF=5.9). 2023. PMID:36891319. DOI: 10.3389/fimmu.2023.1104771.
  • [62] Alexandra M Miggelbrink;Joshua D Jackson;Selena J Lorrey;Ethan S Srinivasan;Jessica Waibl-Polania;Daniel S Wilkinson;Peter E Fecci. CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?. Clinical cancer research : an official journal of the American Association for Cancer Research(IF=10.2). 2021. PMID:34127507. DOI: 10.1158/1078-0432.CCR-21-0206.
  • [63] Jun Wei;Wenting Zheng;Nicole M Chapman;Terrence L Geiger;Hongbo Chi. T cell metabolism in homeostasis and cancer immunity.. Current opinion in biotechnology(IF=7.0). 2021. PMID:33676144. DOI: 10.1016/j.copbio.2021.02.003.
  • [64] Davide G Franchina;Feng He;Dirk Brenner. Survival of the fittest: Cancer challenges T cell metabolism.. Cancer letters(IF=10.1). 2018. PMID:29074426. DOI: 10.1016/j.canlet.2017.10.014.
  • [65] Liangtao Zheng;Shishang Qin;Wen Si;Anqiang Wang;Baocai Xing;Ranran Gao;Xianwen Ren;Li Wang;Xiaojiang Wu;Ji Zhang;Nan Wu;Ning Zhang;Hong Zheng;Hanqiang Ouyang;Keyuan Chen;Zhaode Bu;Xueda Hu;Jiafu Ji;Zemin Zhang. Pan-cancer single-cell landscape of tumor-infiltrating T cells.. Science (New York, N.Y.)(IF=45.8). 2021. PMID:34914499. DOI: 10.1126/science.abe6474.
  • [66] Wael Gamal;Melanie Mediavilla-Varela;Vishaal Kunta;Eva Sahakian;Javier Pinilla-Ibarz. Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia.. Frontiers in cell and developmental biology(IF=4.3). 2025. PMID:40313718. DOI: 10.3389/fcell.2025.1577081.
  • [67] Clare Baecher-Allan;David A Hafler. Human regulatory T cells and their role in autoimmune disease.. Immunological reviews(IF=8.3). 2006. PMID:16903916. DOI: 10.1111/j.0105-2896.2006.00417.x.
  • [68] R Hohlfeld;E Meinl;F Weber;F Zipp;S Schmidt;S Sotgiu;N Goebels;R Voltz;S Spuler;A Iglesias. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis.. Neurology(IF=8.5). 1995. PMID:7783909. DOI: 10.1212/wnl.45.6_suppl_6.s33.
  • [69] Kun-Po Li;Sharmila Shanmuganad;Kaitlin Carroll;Jonathan D Katz;Michael B Jordan;David A Hildeman. Dying to protect: cell death and the control of T-cell homeostasis.. Immunological reviews(IF=8.3). 2017. PMID:28462527. DOI: 10.1111/imr.12538.
  • [70] B C Richardson. T cell receptor usage in rheumatic disease.. Clinical and experimental rheumatology(IF=3.3). 1992. PMID:1582073. DOI: .
  • [71] Taku Kuwabara;Yukihide Matsui;Fumio Ishikawa;Motonari Kondo. Regulation of T-Cell Signaling by Post-Translational Modifications in Autoimmune Disease.. International journal of molecular sciences(IF=4.9). 2018. PMID:29534522. DOI: 10.3390/ijms19030819.
  • [72] Céline Miroux;Thibaut Vausselin;Nadira Delhem. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.. Expert opinion on biological therapy(IF=4.0). 2010. PMID:20932226. DOI: 10.1517/14712598.2010.529125.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

T cells · immune response · adaptive immunity · tumor immunity · autoimmunity

© 2025 MaltSci